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Abstract 
Obesity has been associated with negative effects on natural fertility and poor prognosis when assisted reproduc-
tive technologies (ART) are performed. Patients attending for fertility treatments are often advised to optimize their 
weights to improve the outcomes. There is lack of enough information on how weight-loss would be effective for 
improving fertility in women who are overweight or obese. We conducted a systematic review to evaluate whether 
weight-loss achieved by lifestyle program improves natural or assisted reproduction in obese infertile women. We 
searched CENTRAL, MEDLINE, and EMBASE up to March 2018. Two reviews were selected as randomised tri-
als assessing a lifestyle intervention in women with obesity before receiving treatments for infertility and appraised 
their risk of bias. We extracted data on pregnancy, birth, and miscarriage rates as the primary outcomes and pooled 
effect estimates using a random effects model. The primary outcome was the live birth rate. We reported summary 
measures as the relative risk (RR), 95% confidence interval (CI), and percentage of heterogeneity (I2). We included 
eight randomised trials with 1175 women. Lifestyle programmes, improved pregnancy rates (RR: 1.43, CI: 95% 1.02 
to 2.01; I2=60%; 8 RCTs; N=1098) but had no impact on live births (RR: 1.39, CI: 95% 0.90 to 2.14; I2=64%; 7RCTs; 
N=1034). Our findings suggest that women participating in lifestyle interventions had an increased risk of miscarriage 
(RR: 1.50, CI: 95% 1.04 to 2.16; I2=0; 6RCTs; N=543). We rated the quality of evidence for these outcomes as the 
moderate-to-low. Lifestyle interventions slightly increased the pregnancy rate, while it would be uncertain whether 
it can improve the live birth. Lifestyle interventions can increase the risk of miscarriage. More research is needed to 
further explore lifestyle interventions on reproductive outcomes in obese infertile women.
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Introduction
The prevalence of overweight and obesity among 
women have increased more than three times in the 
last years, creating a global pandemic affecting both 
industrialized and developing countries (1, 2). Obesity 
has been associated with negative effects on both general 
and reproductive health. Natural fertility is compromised 
in both, men and women (3). In the last, polycystic 
ovarian disease (which is typically associated with 
central obesity, insulin resistance, and hyperinsulinism) 
and alterations affecting obesity-related hormones (e.g., 
leptin, adipokines, ghrelin, and endorphins) can affect 
oocyte quality, fertilization, embryo development, and 
implantation, as well as reducing the fertility rate in 
women with a normal menstrual cycle (4-7). The extent of 
impact of obesity on in vitro fertilization (IVF) outcomes 
is unknown due to the heterogeneity of studies conducted 
in this area, the retrospective nature of most investigations, 
and lack of standardized criteria (8-10). Obesity has been 
associated with an increase in gonadotropin need, more 
days of treatment, higher cancellation rates of cycles 
due to the inadequate response, decreased numbers of 
total and mature eggs, reduced rates of fertilization, and 
consequently fewer high-quality embryos. Obesity has 
also been associated with endometrial abnormalities and 
lower implantation rates (11-14). 
Systematic Review 
Int J Fertil Steril, Vol 14, No 1, April-June 2020                 2
Weight-loss has been appreciated as one of the most 
effective means of increasing the probability of fertility 
in infertile overweight or obese women (15, 16). Few 
studies have analyzed the actual effects of a lifestyle 
intervention, including diet and exercise on obese women 
wishing to become pregnant. Additionally, the findings 
of these studies have been inconsistent, probably owing 
to methodological shortcomings (17). A prior systematic 
review, including randomized and non-randomized 
controlled trials and studies using weight reduction 
drugs showed an increase in the feasibility of becoming 
pregnant, with no significant adverse effect on live birth 
rates (18).
In this systematic review, we aimed to evaluate whether 
weight-loss achieved by a lifestyle intervention improved 
the pregnancy outcomes in obese infertile women, with a 
specific focus on the live birth rate. 
Materials and Methods
We conducted this systematic review according to the 
methodological guidance of Cochrane (19). We reported 
the findings from the review according the PRISMA 
statement (20).
Search strategies
We searched MEDLINE (via PubMed), EMBASE 
(via Ovid), and CENTRAL (via The Cochrane Library) 
from the databases inception up to March 2018. We 
designed a search strategy combining text words and 
controlled vocabulary adapted to the requirements 
of each database. We included the complete search 
strings in the Materials S1 (See Supplementary Online 
Information at www.ijfs.ir). Additionally, we searched 
the reference list of all eligible studies and contacted 
authors of the included trials to request additional 
information.
Study selection
We included randomised controlled trials assessing a 
lifestyle intervention in obese women before receiving 
treatments for infertility. The lifestyle interventions that 
we considered in this study consisted of any type of 
structured physical exercise and/or any low calorie intake 
diet refered by the primary included studies. Eligible 
trials included women with a body mass index of 29 or 
higher who were candidates for IVF. The selected trials 
assessed the structured health promotion programmes 
consisting of dietary intake reduction alone or combined 
with physical activity compared with an inactive control 
group (e. g. women on a waiting list) or women receiving 
weight loss advice. Three authors independently evaluated 
whether the references retrieved from the searches met 
the inclusion criteria and resolved disagreements by 
discussion or through adjudication by an additional author. 
We obtained full copies of eligible references for a final 
decision with respective to their inclusion and reported the 
reason that led to exclusion of studies.
Outcomes
We set the following primary outcomes: live birth 
(including spontaneous live birth, IVF live birth and 
cumulative live birth per initial cycle), cumulative 
pregnancy rate and miscarriage (pregnancy ending within 
the first 20 weeks of gestation). Secondary outcomes were 
pregnancy (including multiple pregnancies), ongoing 
pregnancy, and implantation rates.
Data extraction and risk of bias assessment
Two authors extracted independently the relevant 
data from chosen trials using a predefined extraction 
form and an additional author revised the process for 
accuracy. We registered the characteristics of included 
studies in descriptive tables. We contacted authors from 
included studies to request missing data in published 
papers.
We assessed independently the risk of bias from 
included trials using the Cochrane tool for that purpose 
(21). We assessed the trial randomisation sequence 
generation and its concealment, the concealment of the 
intervention to participants, researchers, and outcomes 
assessors, attrition, and incomplete outcome data and 
selective outcome reporting.
Data analysis and findings description
We analysed the effect measures for dichotomous 
variables using risk ratios (RR) and mean differences 
(MD) for continuous variables calculating their 95% 
confidence intervals (CI). We considered statistic 
significant difference between compared groups when 
95% CI was not included. The unit of the analysis of 
interest was the participants in included trials and we 
used the available-case analysis approach to calculate the 
effect estimates.
When appropriate, we calculated pooled effect 
estimates for each outcome using a fixed-effect model 
or a random effect model when there was statistical 
heterogeneity (22). We assessed heterogeneity 
comparing characteristics from included studies and 
through the I square statistics (23) considering a 
substantial statistical heterogeneity for values greater 
than 50% and considerable heterogeneity for values 
greater than 75% scenario in which we did not perform 
the pool effect estimates. We performed sub-group 
analyses according to the lifestyle programme assessed 
in the included trials (diet alone or combined with 
physical activity). We planned sensitivity analyses 
excluding trials with the highest risk of bias or those 
that were a suspected source of heterogeneity. As any 
pooled analyses included more than 10 trials, we were 
not able to conduct formal tests to assess the impact of 
publication bias (24). We used the statistical package 
in the open access software Review Manager (v 5.3.5) 
to conduct all of the analyses (25). We assessed the 
quality of evidence to judge the confidence in the effect 
estimates obtained from each primary outcome. We 
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rated the quality of evidence as high, moderate, low 
or very low according to the impact of each outcome 
on the risk of bias, indirectness, and effect estimates 
inconsistency, and imprecision (26). We summarized 
the effect estimates for primary outcomes and their 
quality of evidence in a summary of the Table of 
findings (27).
Results
Study selection and characteristics
Our search strategy yielded 726 records of which 48 
were potentially eligible to be included. The flowchart 
(Fig.1) describes the complete eligibility process, and 
we describe the reasons for excluding 40 studies and 
the main characteristics of eight included trials (28-
34) in the Materials S2 (See Supplementary Online 
Information at www.ijfs.ir) and the Table 1, respectively. 
Table 2 shows the summary of findings of the review 
with a judgement on their quality of evidence.Fig.1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
726 records identified 
from bibliographic databases 
39 CENTRAL 
264 MEDLINE 
423 EMBASE 
129 duplicates removed 
597 records screened 
according inclusion criteria 
546 records excluded 
by title or abstract 
51 full text articles 
assessed for eligibility 
43 articles excluded 
(See Materials S2) 
20 cohort studies 
9 ineligible study designs 
7 secondary publications from 
included studies 
5 did not include eligible outcomes 
2 ineligible interventions 
8 trials included 
Fig.1: Flowchart for study eligibility.
In total, we included 1175 infertile women. The 
mean age ranged from 29 to 34 years old, and the 
body mass index (BMI) from 24 to 38.  The included 
trials compared lifestyle-structured programmes with 
the usual care. The assessed programmes consisted 
of dietary intake reduction (28-30) or combined with 
physical activity interventions (6, 30-33). Women 
in control groups immediately received infertility 
treatment with no history of interventions or were 
included in a waiting list for IVF (28-30, 32) or 
received standard advice for weight-loss (16, 31, 
34). All lifestyle interventions significantly reduced 
the weight of infertile women compared with control 
group in the Materials S3 (See Supplementary Online 
Information at www.ijfs.ir). The mean weight loos 
values ranged between 3 and 10 kg at the end of the 
intervention. We did not pooled the results of studies 
reporting weight-loss due to the presence of high 
heterogeneity (95%).
Risk of bias
Most trials implemented random sequences 
generated adequately using lists of computer 
generated numbers (16, 29-34) and had proper 
allocation concealment, using opaque envelopes in 
most of the cases (16, 31-34). With the exception of 
one trial (30), the rest was open or did not provide 
details on blinding of researchers or participants, but 
four implemented a blinded outcome assessment (29-
32). We considered three trials having high risk of 
bias because the data available for the analysis were 
partially complete (16, 28, 32). Finally, two trials 
had high risk of selective reporting bias because 
some outcomes included in their protocols did not 
coincide with those reported in the published reports 
of their findings (Fig.2) (28, 34).
Fig.2: Risk of bias.
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Table 1: Characteristics of included studies
Study ID, 
Setting, 
country
Women Age (Y) Mean 
years (SD) 
Experimental/
control group
BMI at baseline 
Mean (SD) 
Experimental/
control group
Experimental 
intervention
Control 
intervention
Outcomes Follow-up 
(months)
Funding
Becker et al. (28), 
2015 Obstetrics 
and Gynaecol-
ogy Service of 
the Hospital de 
Clinicas de Porto 
Alegre, Brazil 
35 31.36 (SE 0.89)/
31.25 (SE 0.78)
28.67 (SE 0.60)/ 
28.82 (SE 0.98)
Hypocaloric diet 
with a low gly-
cemic index and 
low glycemic 
load
Maintenance of 
the body weights 
and usual diets 
Live birth (spontane-
ous) ndesirable 
effects (miscarriage) 
Pregnancy rate (clin-
ical) BMI change 
Weight change
12 Not reported
Einarsson et al. 
(29), 2017 Infer-
tility clinics Swe-
den, Denmark 
and Iceland
317 31.5 (4.3)/
31.7 (4.1)
33.1 (1.3)/
33.0 (1.5)
A low calorie 
liquid formula 
diet of 880 kcal/
day
IVF with no previ-
ous interventions
Live birth 
(spontaneous 
IVF) Undesirable 
effects (miscarriage, 
ectopic pregnancy) 
Pregnancy rate 
(clinical, multiple) 
BMI change Weight 
change
12 Sahlgren-
ska University 
Hospital (ALF-
GBG-70 940), 
Merck AB, 
Solna, Sweden 
(an affiliate of 
Merck KGaA, 
Darmstadt, 
Germany), 
Impolin AB, 
Hjalmar 
Svensson Foun-
dation and Jane 
and Dan Olsson 
Foundation
Espinós et al. 
(30), 2017 
Fertility Unit of 
Hospital de la 
Santa Creu i Sant 
Pau-Fundacio Pu-
igvert, Barcelona 
Spain
41 32.0 (3.2)/
32.9 (3.9)
34.6 (3.0)/
34.0 (4.1)
Diet and exercise IVF/ICSI with no 
previous interven-
tions
Live birth (IVF, 
cumulative) Undesir-
able effects (miscar-
riage) Pregnancy rate 
(clinical, multiple) 
Weight change 
Implantation rate 
Fertilization rate
12 Grant from the 
Instituto de 
Salud Carlos III 
(PI11/02816)
Moran et al. (31), 
2016 Repromed, 
Adelaide Aus-
tralia
46 33.8 (3.5)/
32.5 (3.3)
34.0 (4.5)/
33.9 (4.4)
A nutritionally 
adequate reduced 
energy diet and 
exercise interven-
tion andcontact 
with investigators
A standard advice 
on appropriate 
diet and lifestyle 
factors influencing 
fertility provided 
face-to face at one 
session with no 
active follow-up
Live birth Undesir-
able effects (miscar-
riage) Pregnancy rate 
BMI change Weight 
change
Not 
reported
NHMRC Pro-
gram Grant to 
RJN, a Brails-
ford Robertson 
Grant and The 
University of 
Adelaide in 
Adelaide, 
Australia, and 
sponsored with 
a product (Opti-
fast VLCD) by 
Novartis USA
Mutsaerts et 
al. (32), 2016 
University medi-
cal centres and 
general hospitals 
Netherlands
577 29.7 (4.5)/
29.8 (4.6)
27.7 
(range 24.4-31.0)/
Motivational 
counselling: 
outpatient 
visits, telephone 
consultations, 
assistance of an 
online diet diary, 
advise to engage 
in moderate 
intensity physical 
activity
Prompt infertility 
treatment with no 
previous interven-
tions
Live birth Undesir-
able effects (miscar-
riage) Pregnancy rate 
(clinical, multiple) 
BMI change Weight 
change
24 Grant (50-
50110-96-518) 
from the 
Netherlands 
Organization 
for Health 
Research and 
Development
Palomba et al. 
(33), 2010* 
Setting Units of 
Reproductive 
Medicine and 
Surgery Italy
96 28.43 (8.31)/
26.50 (4.26)
31.05 (2.98)/
32.3 (3.73)
Structured 
exercise training 
plus hypocaloric 
diet for 6 weeks, 
with one cycle of 
CC after the first 
2 weeks
2 weeks of obser-
vation followed 
by one cycle of 
CC therapy
BMI change Weight 
change Ovulation 
rate Reproductive 
outcomes Changes 
in anthropometric 
and hormonal and 
metabolic param-
eters Compliance 
with the interven-
tions 
Not 
reported
Not reported
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Effect of lifestyle interventions in primary outcomes
Seven studies reported the live birth with a total 
number of 1034 patients (28-34), and showed that 
lifestyle interventions had no effect on live birth rates 
(RR: 1.39, CI: 95% 0.90 to 2.14; I2=65%; Fig.3).
We rated this outcome as low-quality due to limitations 
in study designs and imprecision in the effect estimate. On 
the other hand, the intervention led to higher pregnancy rates 
according the pooled results of seven trials including 1098 
women (RR: 1.43, CI: 95% 1.02 to 2.01; I2=60%; Fig.4) (16, 
28-31, 33). Twenty-one more women out 100 participating 
in a lifestyle intervention became pregnant in comparison to 
women receiving usual care (CI: 95% 0.5 to 38 more). 
A subgroup analysis of studies assessing interventions 
based on dietary restriction (28, 29) or in combination with 
physical activity (16, 30-32, 34) did not show changes any 
the effect estimates magnitude or direction (in the Materials 
S4, See Supplementary Online Information at www.ijfs.ir).
Table 1: Continued
Study ID, 
Setting, 
country
Women Age (Y) Mean 
years (SD) 
Experimental/
control group
BMI at baseline 
Mean (SD) 
Experimental/
control group
Experimental 
intervention
Control 
intervention
Outcomes Follow-up 
(months)
Funding
Rothberg et 
al. (34), 2016 
University of 
Michigan (UM) 
Health System, 
Ann Arbor, 
Michigan USA
14 33 (5.0)/
30 (4.0)
41 (4)/
41 (4)
Intensive weight 
loss interventions 
consisted of 12 
weeks of very-
low-energy diet 
(800 kcal/day)  
plus 4 weeks of 
a low-calorie 
conventional 
food-based diet 
Standard-of-care 
nutritional coun-
selling consisted 
of 16 weeks of 
conventional 
food-based diet
Live birth Pregnancy 
rate BMI change 
Weight change
12 Grant from the 
Michigan Insti-
tute for Clinical 
Research (grant 
U040012 PI 
to A.R.); the 
core services of 
the Michigan 
Nutrition Obe-
sity Research 
Centre (grant 
DK089503); 
and the Michi-
gan Centre 
for Diabetes 
Research (grant 
P30DK020572)
Sim et al. (16), 
2014, Royal 
Prince Alfred 
Hospital (RPAH) 
Fertility Unit, 
Sydney, Australia
49 32,9 (3.3)/
32,8 (3.1)
35.1 (3.8)/
38.0 (5.2)
A very-low-en-
ergy diet for the 
initial 6 weeks 
followed by a 
hypocaloric diet, 
combined with 
a weekly group 
multidisciplinary 
programme
Recommenda-
tions for weight 
loss and the same 
printed material as 
the intervention.
Live birth Undesir-
able effects (miscar-
riage) Pregnancy rate 
(clinical, assisted, 
natural) BMI change 
Weight change
12 National Health 
and Medical 
Research Coun-
cil of Australia 
and from the 
Sydney Univer-
sity Nutrition 
Research 
Foundation to 
KAS. Prima 
Health Solu-
tions provided 
the VLED 
(KicStart)
SD; Standard deviation, SE; Standard error, CC; Clomiphene citrate, BMI; Body mass index, IVF; In vitro fertilization, ICSI; Intracytoplasmic sperm injection, *; Palomba et al. study had 3 
groups, but we include only group B and C described in the Table. The group A received structured exercise training plus hypocaloric diet for 6 weeks without CC.
Table 2: Summary of review findings
Outcomes
Anticipated absolute effects (95% CI) Relative effect (95% CI) Number of participants Quality of the evidence
Risk with usual care Risk with lifestyle interventions (*)
Live births
IVF live births
242 per 1.000 346 per 1.000
(181 to 655)
RR 1.43
(0.75 to 2.71)
433 (4 RCTs)
Low1, 2
Live births 
All live births
405 per 1.000 563 per 1.000
(365 to 867)
RR 1.39
(0.90 to 2.14)
1034 (7 RCTs)
Low2, 3
All pregnancies 502 per 1.000 718 per 1.000
(507 to 1.000)
RR 1.43
(1.01 to 2.02)
1034 (7 RCTs)
Moderate3
Miscarriage 142 per 1.000 213 per 1.000
(148 to 307)
RR 1.50
(1.04 to 2.16)
543 (6 RCTs)
Moderate4
*; The risk in the intervention group [and its 95% confidence interval (CI)] is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% 
CI), 1; Two studies had high risk of performance bias (open trials), and additional one high risk of attrition bias, 2; The confidence interval of effect estimate includes both an effect for the 
intervention and the control condition, 3; Five studies had high risk of performance bias or detection bias (open trials), and two reported selectively their outcomes, and 4; Four studies had 
high risk of performance bias or detection bias (open trials), three had high risk of attrition bias and one reported selectively its outcomes. Grade working group grades of evidence: High 
quality; Further research is very unlikely to change our confidence in the estimate of effect. Moderate quality; Further research is likely to have an important impact on our confidence 
in the estimate of effect and may change the estimate. Low quality; Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to 
change the estimate. Very low quality; We are very uncertain about the estimate.
Espinós et al.
Int J Fertil Steril, Vol 14, No 1, April-June 2020                 6
Notably, the results from six studies with a total number 
of 543 participants (16, 28-32) showed a statistically 
significant increase in the risk of miscarriage in women 
allocated to lifestyle interventions (RR: 1.50, CI: 95% 
1.04 to 2.16; I2=0; Fig.5), resulting in seven women more 
out of 100 allocated to lifestyle interventions having a 
miscarriage in comparison to women receiving usual 
care (CI: 95% 0.6 to 9 more). We rated pregnancy rates 
and miscarriage as moderate quality due to limitations 
in studies design. This increase in the risk of miscarriage 
disappeared in a subgroup analysis of interventions that 
were exclusively based on a dietary restriction according 
Lifestyle Intervention in Obese Infertile Women 
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Study or subgroup 
Becker et al. (28), 2015  
Einarsson et al. (29), 2017  
Espinos et al. (30), 2017  
Moran et al. (31), 2016  
Mutsaerts et al. (32), 2016  
Rothberg et al. (33), 2016  
Sim et al. (16), 2014  
Subtotal (95% CI) 
Total events 
Heterogeneity: Tau²=0,15; Chi²=17,11, df=6 (P=0,009); I² = 65% 
Test for overall effect: Z=1,49 (P=0,14) 
Events 
3 
45 
13 
7 
123 
3 
12 
206 
Total 
14 
152 
21 
18 
280 
6 
27 
518 
Events 
0 
42 
6 
5 
153 
0 
3 
209 
Total 
12 
153 
20 
20 
284 
5 
22 
516 
Weight 
2,1% 
26,3% 
16,3% 
12,5% 
30,5% 
2,3% 
10,0% 
100,0% 
M-H, Random, 95% CI 
6,07 [0,34, 106,85] 
1,08 [0,76, 1,54] 
2,06 [0,98, 4,36] 
1,56 [0,60, 4,04] 
0,82 [0,69, 0,97] 
6,00 [0,38, 94,35] 
3,26 [1,05, 10,12] 
1,39 [0,90, 2,14] 
Lifestyle interventions Usual care Risk ratio Risk ratio 
M-H, Random, 95% CI 
0.01 0.1 1 10 100 
Usual care Lifestyle intervention 
Fig.3: Live Birth-pooled analysis.
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Study  
Becker et al. (28), 20151  
Einarsson et al. (29), 2017 
Espinos et al. (30), 2017 
Moran et al. (31), 2016 
Mutsaerts et al. (32), 2016 
Palomba et al. (33), 2010 
Rothberg et al. (34), 2016 
Sim et al. (16), 2014 
Total (95% CI) 
Total events 
Heterogeneity: Tau²=0.09; Chi²=17.40, df=7 (P=0.01); I²=60% 
Test for overall effect: Z=2.07 (P=0.04) 
Events 
3 
66 
13 
12 
175 
1 
3 
13 
286 
Total 
14 
152 
21 
18 
280 
32 
6 
27 
550 
Events 
0 
56 
6 
8 
186 
0 
0 
3 
259 
Total 
12 
153 
20 
20 
284 
32 
5 
22 
548 
Weight 
1.3% 
27.8% 
12.8% 
15.7% 
32.6% 
1.1% 
1.5% 
7.2% 
100.0% 
M-H, Random, 95% CI 
6.07 [0.34, 106.85] 
1.19 [0.90, 1.56] 
2.06 [0.98, 4.36] 
1.67 [0.89, 3.12] 
0.95 [0.84, 1.08] 
3.00 [0.13, 71.00] 
6.00 [0.38, 94.35] 
3.53 [1.15, 10.84] 
1.43 [1.02, 2.01] 
Lifestyle interventions Usual care Risk ratio 
 
1; Three women in the intervention group experienced 3 spontaneous pregnancies. 
Risk ratio 
M-H, Random, 95% CI 
0.005 0.1 1 10 200 
Usual care Lifestyle interventions 
Fig.4: Pregnancy rate-pooled analysis.Fig.5 
 
 
 
Study or subgroup 
Becker et al. (28), 2015  
Einarsson et al. (29), 2017  
Espinos et al. (30), 2017  
Moran et al. (31), 2016  
Mutsaerts et al. (32), 2016  
Sim et al. (16), 2014  
Total (95% CI) 
Total events 
Heterogeneity: Chi²=1,26, df=4 (P=0,87); I²=0% 
Test for overall effect: Z=2,16 (P=0,03) 
Events 
0 
8 
1 
5 
42 
5 
61 
Total 
3 
66 
14 
12 
175 
13 
283 
Events 
0 
5 
1 
3 
27 
1 
37 
Total 
0 
56 
7 
8 
186 
3 
260 
Weight 
14,2% 
3,5% 
9,4% 
68,6% 
4,3% 
100,0% 
M-H, Fixed, 95% CI 
Not estimable 
1,36 [0,47, 3,91] 
0,50 [0,04, 6,86] 
1,11 [0,36, 3,40] 
1,65 [1,07, 2,56] 
1,15 [0,20, 6,59] 
1,50 [1,04, 2,16] 
Lifestyle interventions Usual care Risk ratio Risk ratio 
M-H, Fixed, 95% CI 
0.005 0.1 1 10 200 
Usual care Lifestyle intervention 
Fig.5: Miscarriage-pooled analysis.
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the pooled results from two trials (125 participants; RR: 
1.36; 95% CI: 0.47 to 3.91; I2=0) (Materials S4, See 
Supplementary Online Information at www.ijfs.ir).
After exploring possible sources of heterogeneity, 
we performed a sensitivity analysis excluding from 
the pooled analyses one trial that could have an impact 
on the consistency of effect estimates (32). The results 
of these analyses resulted in a statistically significant 
increase in live birth rates that favoured the intervention 
(6 trials, 470 participants; RR: 1.69; 95% CI: 1.05 to 
2.70; I2=34%), while the impact on miscarriage switched 
to a non-significant difference (5 trials, 182 participants; 
RR: 1.16; 95% CI: 0.59 to 2.30; I2=0%) (Materials S5) 
(See Supplementary Online Information at www.ijfs.ir).
Cumulative pregnancy rate was not reported in the 
included studies.
Effect of lifestyle interventions in secondary outcomes
The participation in a lifestyle intervention did not 
show differences, compared to the usual care, in the 
rate of ongoing pregnancies (32) (317 participants; RR: 
0.91, CI: 95% 0.79 to 1.05) or implantation rates (30) 
(65 participants; RR: 1.32, CI: 95% 0.72 to 1.69). We 
rated these outcomes as low due to the imprecision in 
effect estimates. 
Discussion
We included eight trials, providing a total of 1175 
infertile obese women randomised to receive a type of 
diet and/or exercise structured program versus usual care 
before undergoing an assisted reproduction program. 
In all included studies, experimental interventions 
significantly lowered the women’s weight; however, 
there were some variations in the measure effects between 
the studies. The main findings of our systematic review 
suggests that lifestyle interventions may have little or no 
impact on the live birth rates of obese infertile women 
who wish pregnancy.
On the other hand, our results showed an increase 
in the risk of miscarriage rate in seven more pregnant 
women out of 100 receiving the intervention instead 
of the usual care. The sub-group analyses according to 
the components of the intervention of interest (dietary 
restriction alone or in combination with physical 
activity) did not have major impact on our findings. No 
studies reported the cumulative pregnancy rate.
Our review surveyed rigorous methodological 
standards, and we set the methods used in our review in 
a protocol prospectively registered. Most of the review 
steps were conducted independently by pairs of reviews 
to ensure the accuracy of judgements and data. We made 
an effort to identify all the relevant trials eligible for our 
inclusion criteria and asked missing data in published 
reports to the authors to avoid selective reporting bias. The 
review has also some limitations, and we obtained few 
missing data from trials and the data extracted from trial 
reports. This fact did not allow us to undertake reliable 
analysis to explore the effects of the intervention in 
terms of different characteristics of women participating 
in other studies, the interventions assessed or the control 
conditions. Also, we limited inclusion to randomised 
trials that allowed us to obtain reliable effect estimates 
but omitted the results from a body of controlled 
observational studies (see excluded studies at Materials 
S2, See Supplementary Online Information at www.ijfs.
ir) that could bring light to the findings of our review. 
We also found some high heterogeneity related with the 
different types of interventions for reducing weight and 
the discrepancies in women’s characteristics, such as 
age and the baseline values of women’s weight between 
studies. We rated the quality of evidence for primary 
outcomes as moderate-to-low due to the limitations in 
the included studies design and the imprecision in effect 
estimates.
The increase in the miscarriage rate is an unexpected 
finding since obesity has been related to a lower oocyte 
quality and endometrial receptivity increasing the risk 
of pregnancy loss. However, the study by Mutsaerts et 
al. (32) in comparison with the other studies introduced 
clinical heterogeneity because women had lower 
BMI and the control group received a higher number 
of infertility treatments; furthermore, the assessed 
intervention lasted for a longer period and the study 
presented attrition bias (22% of losses). For these 
reasons, we excluded Mutsaerts et al. (32) study in the 
sensitivity analysis. In consequence, results changed to 
lifestyle interventions increased of live birth and there 
was not difference in the risk of miscarriage compared 
with the control group. These results are more consistent 
with recent data that show an association of weight gain 
≥5% with a higher risk of pregnancy loss compared with 
maintaining a constant weight. The weight loss ≥5% did 
not associate with the increased risk of pregnancy loss 
(35). Other systematic reviews have reported the effect 
of diet and/or exercise on obese fertile women. One 
review (36) assessed the effect of low carbohydrate diet 
on fertility hormones and pregnancy in overweight and 
obese women with a methodology that differed from our 
review and with inconclusive results regarding the impact 
of intervention on the pregnancy rate. Another review 
also focused on assessed weight-loss interventions in 
overweight and obese women with broader inclusion 
criteria (the review included non-randomized studies 
and also assessed weight reduction drugs) (18). Pooled 
analysis from randomized trials showed similar results 
for the pregnancy rate and live birth, but did not show 
any increase in the rate of miscarriage, as shown by our 
findings.
Lifestyle intervention programmes targeted to people 
with overweight or obesity usually result in poor 
compliance rates and gender have been identified as one 
of the critical predictors for adherence, which is lower 
in women (37). On the other hand, a great majority of 
obese women facing an infertility treatment with interest 
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in a supervised medical weight-loss programme would 
not be willing to delay the fertility treatment more 
than three months to attempt weight-loss (38). These 
considerations are relevant in the light of the review 
findings when making a decision to initiate a programme 
such those described but facing low expectations from 
it in terms of the fertility treatment success. In that 
context, an individualized and shared decision should be 
made exploring patient motivation and other compliance 
predictors, such as age, baseline BMI, and mood (37).
Conclusion
Lifestyle interventions in obese infertile women 
based on dietary restrictions and physical activity 
probably lead to a slightly increase in the pregnancy rate 
compared with the usual care and make little difference 
in the improvement of live birth. Furthermore, our 
findings suggested a link between these interventions 
and a slightly increase of the risk of miscarriage. More 
research is needed in obese women undergoing infertility 
programs to further confirm or refute our findings. 
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